CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening ...

First-ever use of Ebenbuild's Twinhale technology  in idiopathic pulmonary fibrosis lung modelsTrial results published in Nature Communications Munich, Germany - April 9, 2025 -- Ebenbuild, a company ...

The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

Pulmonary sarcoidosis is a lung disease characterized by granulomas -- tiny clumps of immune cells that form in response to inflammation. It's the most inflammatory of the interstitial lung diseases ...

Backed Nutritional Solution Targeting Respiratory and Liver Health Through Natural Detox PathwaysSheridan, April 05, 2025 ...